Form 8-K - Current report:
SEC Accession No. 0001493152-25-006588
Filing Date
2025-02-14
Accepted
2025-02-14 08:00:34
Documents
15
Period of Report
2025-02-11
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40014
2 ex3-1.htm EX-3.1 9715
  Complete submission text file 0001493152-25-006588.txt   230019

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE pulm-20250211.xsd EX-101.SCH 3018
4 XBRL LABEL FILE pulm-20250211_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE pulm-20250211_pre.xml EX-101.PRE 24167
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3805
Mailing Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701
Business Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701 (888) 355-4440
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36199 | Film No.: 25623316
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)